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EXECUTIVE SUMMARY
The global war on drugs has failed, with 
devastating consequences for individuals 
and societies around the world. Fifty years  
after the initiation of the UN Single 
Convention on Narcotic Drugs, and  
40 years after President Nixon launched  
the US government’s war on drugs, 
fundamental reforms in national and global 
drug control policies are urgently needed.
Vast expenditures on criminalization and 
repressive measures directed at producers, 
traffickers and consumers of illegal drugs 
have clearly failed to effectively curtail 
supply or consumption. Apparent victories 
in eliminating one source or trafficking 
organization are negated almost instantly 
by the emergence of other sources and 
traffickers. Repressive efforts directed at 
consumers impede public health measures 
to reduce HIV/AIDS, overdose fatalities  
and other harmful consequences of  
drug use. Government expenditures on  
futile supply reduction strategies and 
incarceration displace more cost-effective 
and evidence-based investments in  
demand and harm reduction.
 
Our principles and recommendations can 
be summarized as follows:
 
End the criminalization, marginalization  
and stigmatization of people who use drugs 
but who do no harm to others. Challenge 
rather than reinforce common misconceptions 
about drug markets, drug use and  
drug dependence. 
 
Encourage experimentation by governments 
with models of legal regulation of drugs to 
undermine the power of organized crime 
and safeguard the health and security of 
their citizens. This recommendation applies 
especially to cannabis, but we also encourage 
other experiments in decriminalization and 
legal regulation that can accomplish these 
objectives and provide models for others.
Offer health and treatment services to those 
in need. Ensure that a variety of treatment 
modalities are available, including not just 
methadone and buprenorphine treatment but 
also the heroin-assisted treatment programs 
that have proven successful in many European 
countries and Canada. Implement syringe 
access and other harm reduction measures 
that have proven effective in reducing 
transmission of HIV and other blood-borne 
infections as well as fatal overdoses. Respect 
the human rights of people who use drugs. 
Abolish abusive practices carried out in the 
name of treatment – such as forced detention, 
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forced labor, and physical or psychological 
abuse – that contravene human rights 
standards and norms or that remove the 
right to self-determination.
 
Apply much the same principles and 
policies stated above to people involved 
in the lower ends of illegal drug markets, 
such as farmers, couriers and petty sellers. 
Many are themselves victims of violence 
and intimidation or are drug dependent. 
Arresting and incarcerating tens of millions 
of these people in recent decades has filled 
prisons and destroyed lives and families 
without reducing the availability of illicit 
drugs or the power of criminal organizations. 
There appears to be almost no limit to  
the number of people willing to engage in 
such activities to better their lives, provide 
for their families, or otherwise escape 
poverty. Drug control resources are better 
directed elsewhere.
Invest in activities that can both prevent 
young people from taking drugs in the 
first place and also prevent those who do 
use drugs from developing more serious 
problems. Eschew simplistic ‘just say no’ 
messages and ‘zero tolerance’ policies 
in favor of educational efforts grounded 
in credible information and prevention 
programs that focus on social skills and peer 
influences. The most successful prevention 
efforts may be those targeted at specific  
at-risk groups.
Focus repressive actions on violent  
criminal organizations, but do so in ways  
that undermine their power and reach  
while prioritizing the reduction of violence 
and intimidation. Law enforcement  
efforts should focus not on reducing drug 
markets per se but rather on reducing their 
harms to individuals, communities and 
national security.
Begin the transformation of the global  
drug prohibition regime. Replace drug 
policies and strategies driven by ideology 
and political convenience with fiscally 
responsible policies and strategies  
grounded in science, health, security and 
human rights – and adopt appropriate 
criteria for their evaluation. Review the 
scheduling of drugs that has resulted 
in obvious anomalies like the flawed 
categorization of cannabis, coca leaf and 
MDMA. Ensure that the international 
conventions are interpreted and/or revised 
to accommodate robust experimentation 
with harm reduction, decriminalization and 
legal regulatory policies.
 
Break the taboo on debate and reform.  
The time for action is now.
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The global war on drugs has failed. When the United 
Nations Single Convention on Narcotic Drugs came into 
being 50 years ago, and when President Nixon launched the 
US government’s war on drugs 40 years ago, policymakers 
believed that harsh law enforcement action against those 
involved in drug production, distribution and use would 
lead to an ever-diminishing market in controlled drugs 
such as heroin, cocaine and cannabis, and the eventual 
achievement of a ‘drug free world’. In practice, the global 
scale of illegal drug markets – largely controlled by 
organized crime – has grown dramatically over this period. 
While accurate estimates of global consumption across the 
entire 50-year period are not available, an analysis of the  
last 10 years alone1,2,3,4 shows a large and growing market. 
(See chart above.)
In spite of the increasing evidence that current policies are 
not achieving their objectives, most policymaking bodies 
at the national and international level have tended to avoid 
open scrutiny or debate on alternatives. 
This lack of leadership on drug policy has prompted the 
establishment of our Commission, and leads us to our view 
that the time is now right for a serious, comprehensive 
and wide-ranging review of strategies to respond to the 
drug phenomenon. The starting point for this review is 
the recognition of the global drug problem as a set of 
interlinked health and social challenges to be managed, 
rather than a war to be won. 
Commission members have agreed on four core principles 
that should guide national and international drug policies 
and strategies, and have made eleven recommendations  
for action.
INTRODUCTION
UNITED NATIONS ESTIMATES OF ANNUAL DRUG 
CONSUMPTION, 1998 TO 2008 
1998
2008
% Increase
Opiates
12.9 million
17.35 million
34.5%
Cocaine
13.4 million
17 million
27%
Cannabis
147.4 million
160 million
8.5%
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PRINCIPLES
1.  Drug policies must be based on solid empirical and 
scientific evidence. The primary measure of success 
should be the reduction of harm to the health, 
security and welfare of individuals and society. 
 In the 50 years since the United Nations initiated a truly 
global drug prohibition system, we have learned much 
about the nature and patterns of drug production, 
distribution, use and dependence, and the effectiveness 
of our attempts to reduce these problems. It might have 
been understandable that the architects of the system 
would place faith in the concept of eradicating drug 
production and use (in the light of the limited evidence 
available at the time). There is no excuse, however, for 
ignoring the evidence and experience accumulated  
since then. Drug policies and strategies at all levels too 
often continue to be driven by ideological perspectives, 
or political convenience, and pay too little attention  
to the complexities of the drug market, drug use and 
drug addiction.
 Effective policymaking requires a clear articulation of the 
policy’s objectives. The 1961 UN Single Convention on 
Narcotic Drugs made it clear that the ultimate objective 
of the system was the improvement of the ‘health and 
welfare of mankind’. 
 This reminds us that drug policies were initially 
developed and implemented in the hope of achieving 
outcomes in terms of a reduction in harms to individuals 
and society – less crime, better health, and more 
economic and social development. However, we have 
primarily been measuring our success in the war on 
drugs by entirely different measures – those that report 
on processes, such as the number of arrests, the 
amounts seized, or the harshness of punishments. These 
indicators may tell us how tough we are being, but they 
do not tell us how successful we are in improving the 
‘health and welfare of mankind’.
2.  Drug policies must be based on human rights 
and public health principles. We should end the 
stigmatization and marginalization of people who  
use certain drugs and those involved in the lower 
levels of cultivation, production and distribution,  
and treat people dependent on drugs as patients,  
not criminals. 
 Certain fundamental principles underpin all aspects of 
national and international policy. These are enshrined 
in the Universal Declaration of Human Rights and many 
international treaties that have followed. Of particular 
relevance to drug policy are the rights to life, to health, 
to due process and a fair trial, to be free from torture 
or cruel, inhuman or degrading treatment, from slavery, 
and from discrimination. These rights are inalienable, 
and commitment to them takes precedence over other 
international agreements, including the drug control 
conventions. As the UN High Commissioner for Human 
Rights, Navanethem Pillay, has stated, “Individuals 
who use drugs do not forfeit their human rights. Too 
often, drug users suffer discrimination, are forced to 
accept treatment, marginalized and often harmed by 
approaches which over-emphasize criminalization and 
punishment while under-emphasizing harm reduction 
and respect for human rights.”5 
 A number of well-established and proven public 
health measures6,7 (generally referred to as harm 
reduction, an approach that includes syringe access and 
treatment using the proven medications methadone or 
buprenorphine) can minimize the risk of drug overdose 
deaths and the transmission of HIV and other blood-
borne infections.8 However, governments often do not 
fully implement these interventions, concerned that by 
improving the health of people who use drugs, they 
are undermining a ‘tough on drugs’ message. This is 
illogical – sacrificing the health and welfare of one group 
of citizens when effective health protection measures are 
available is unacceptable, and increases the risks faced 
by the wider community.
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Countries that implemented harm reduction and public 
health strategies early have experienced consistently low 
rates of HIV transmission among people who inject drugs. 
Similarly, countries that responded to increasing HIV 
prevalence among drug users by introducing harm reduction 
programs have been successful in containing and reversing 
the further spread of HIV. On the other hand, many countries 
that have relied on repression and deterrence as a response 
to increasing rates of drug-related HIV transmission are 
experiencing the highest rates of HIV among drug using 
populations.10,11,12
An indiscriminate approach to ‘drug trafficking’ is similarly 
problematic. Many people taking part in the drug market are 
themselves the victims of violence and intimidation, or are 
dependent on drugs. An example of this phenomenon are 
the drug ‘mules’ who take the most visible and risky roles in 
the supply and delivery chain. Unlike those in charge of drug 
trafficking organizations, these individuals do not usually have 
an extensive and violent criminal history, and some engage 
in the drug trade primarily to get money for their own drug 
dependence. We should not treat all those arrested for 
trafficking as equally culpable – many are coerced into their 
actions, or are driven to desperate measures through their 
own addiction or economic situation. It is not appropriate to 
punish such individuals in the same way as the members of 
violent organized crime groups who control the market.
Finally, many countries still react to people dependent on 
drugs with punishment and stigmatization. In reality, drug 
dependence is a complex health condition that has a mixture 
of causes – social, psychological and physical (including, for 
example, harsh living conditions, or a history of personal 
trauma or emotional problems). Trying to manage this 
complex condition through punishment is ineffective – much 
greater success can be achieved by providing a range of 
evidence-based drug treatment services. Countries that have 
treated citizens dependent on drugs as patients in need of 
treatment, instead of criminals deserving of punishment, have 
demonstrated extremely positive results in crime reduction, 
health improvement, and overcoming dependence. 
IMPACT OF DRUG POLICIES  
ON RECENT HIV PREVALENCE 
AMONG PEOPLE WHO  
INJECT DRUGS9
Sample of countries that have consistently 
implemented comprehensive harm reduction 
strategies:
Sample of countries that have introduced harm 
reduction strategies partially, or late in the 
progress of the epidemic:
Sample of countries that have consistently 
resisted large scale implementation of harm 
reduction strategies, despite the presence of  
drug injecting and sharing:
UK
Switzerland
Germany
Australia
USA
Portugal
Malaysia
France
Thailand
Russia
 0 5 10 15 20 25 30 35 40 45
   % HIV prevalence among people who inject drugs
 0 5 10 15 20 25 30 35 40 45
   % HIV prevalence among people who inject drugs
 0 5 10 15 20 25 30 35 40 45
   % HIV prevalence among people who inject drugs
PRINCIPLES
(Continued)
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 Case Study One: Switzerland13  
 In response to severe and highly visible drug 
problems that developed across the country in 
the 1980s, Switzerland implemented a new set of 
policies and programs (including heroin substitution 
programs) based on public health instead of 
criminalization. The consistent implementation  
of this policy has led to an overall reduction in  
the number of people addicted to heroin as well  
as a range of other benefits. A key study14 
concluded that: 
 “Heroin substitution targeted hard-core 
problematic users (heavy consumers) – assuming 
that 3,000 addicts represent 10 percent to  
15 percent of Switzerland’s heroin users that may 
account for 30 percent to 60 percent of the demand 
for heroin on illegal markets. Heavily engaged in 
both drug dealing and other forms of crime, they 
also served as a link between wholesalers and users. 
As these hard-core users found a steady, legal 
means for their addiction, their illicit drug use was 
reduced as well as their need to deal in heroin  
and engage in other criminal activities.
 The heroin substitution program had three effects 
on the drug market:
•	 It	substantially	reduced	the	consumption	among	
the heaviest users, and this reduction in demand 
affected the viability of the market. (For example, 
the number of new addicts registered in Zurich  
in 1990 was 850. By 2005, the number had  
fallen to 150.)
•		It	reduced	levels	of	other	criminal	activity	
associated with the market. (For example, there 
was a 90 percent reduction in property crimes 
committed by participants in the program.)
•		By	removing	local	addicts	and	dealers,	Swiss	casual	
users found it difficult to make contact with sellers.”
PATIENTS NOT CRIMINALS: 
A MORE HUMANE AND EFFECTIVE APPROACH
 Case Study Two: United Kingdom15
 Research carried out in the UK into the effects 
of their policy of diversion from custody into 
treatment programs clearly demonstrated a 
reduction in offending following treatment 
intervention. In addition to self-reports, the 
researchers in this case also referred to police  
criminal records data. The research shows  
that the numbers of charges brought against  
1,476 drug users in the years before and after 
entering treatment reduced by 48 percent.
 Case Study Three: The Netherlands16,17,18
 Of all EU-15 countries, the percentage of people 
who inject heroin is the lowest in the Netherlands 
and there is no new influx of problematic users. 
Heroin has lost its appeal to the mainstream youth 
and is considered a ‘dead-end street drug’.  
The number of problematic heroin users has 
dropped significantly and the average age of users 
has risen considerably. Large-scale, low-threshold 
drug treatment and harm reduction services 
include syringe access and the prescription of 
methadone and heroin under strict conditions. 
 Medically prescribed heroin has been found 
in the Netherlands to reduce petty crime and 
public nuisance, and to have positive effects on 
the health of people struggling with addiction. 
In 2001, the estimated number of people in the 
Netherlands dependent on heroin was 28-30,000. 
By 2008, that number had fallen to 18,000.  
The Dutch population of opiate users is in the 
process of aging – the proportion of young 
opiate users (aged 15-29) receiving treatment for 
addiction has also declined. 
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3.  The development and implementation of drug 
policies should be a global shared responsibility,  
but also needs to take into consideration diverse 
political, social and cultural realities. Policies should 
respect the rights and needs of people affected  
by production, trafficking and consumption, as 
explicitly acknowledged in the 1988 Convention  
on Drug Trafficking. 
 The UN drug control system is built on the idea that 
all governments should work together to tackle drug 
markets and related problems. This is a reasonable 
starting point, and there is certainly a responsibility to 
be shared between producing, transit and consuming 
countries (although the distinction is increasingly blurred, 
as many countries now experience elements of all three).
 However, the idea of shared responsibility has too often 
become a straitjacket that inhibits policy development 
and experimentation. The UN (through the International 
Narcotics Control Board), and in particular the US 
(notably through its ‘certification’ process), have worked 
strenuously over the last 50 years to ensure that all 
countries adopt the same rigid approach to drug policy 
– the same laws, and the same tough approach to their 
enforcement. As national governments have become 
more aware of the complexities of the problems, and 
options for policy responses in their own territories, 
many have opted to use the flexibilities within the 
Conventions to try new strategies and programs, such as 
decriminalization initiatives or harm reduction programs. 
When these involve a more tolerant approach to drug 
use, governments have faced international diplomatic 
pressure to ‘protect the integrity of the Conventions’, 
even when the policy is legal, successful and supported 
in the country.
A current example of this process (what may be described 
as ‘drug control imperialism’), can be observed with the 
proposal by the Bolivian government to remove the  
practice of coca leaf chewing from the sections of the  
1961 Convention that prohibit all non-medical uses.  
Despite the fact that successive studies have shown19 that 
the indigenous practice of coca leaf chewing is associated 
with none of the harms of international cocaine markets, 
and that a clear majority of the Bolivian population (and 
neighboring countries) support this change, many of the 
rich ‘cocaine consumer’ countries (led by the US) have 
formally objected to the amendment.20 
The idea that the international drug control system is 
immutable, and that any amendment – however reasonable 
or slight – is a threat to the integrity of the entire system, 
is short-sighted. As with all multilateral agreements, the 
drug conventions need to be subject to constant review 
and modernization in light of changing and variable 
circumstances. Specifically, national governments must 
be enabled to exercise the freedom to experiment with 
responses more suited to their circumstances. This analysis 
and exchange of experiences is a crucial element of the 
process of learning about the relative effectiveness of 
different approaches, but the belief that we all need to have 
exactly the same laws, restrictions and programs has been 
an unhelpful restriction.
PRINCIPLES
(Continued)
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 UNINTENDED CONSEQUENCES
 The implementation of the war on drugs has generated 
widespread negative consequences for societies in  
producer, transit and consumer countries. These 
negative consequences were well summarized by the 
former Executive Director of the United Nations Office 
on Drugs and Crime, Antonio Maria Costa, as falling into 
five broad categories:
1. The growth of a ‘huge criminal black market’, financed 
by the risk-escalated profits of supplying international 
demand for illicit drugs. 
2. Extensive policy displacement, the result of using scarce 
resources to fund a vast law enforcement effort intended 
to address this criminal market.
3. Geographical displacement, often known as ‘the balloon 
effect’, whereby drug production shifts location to avoid 
the attentions of law enforcement.
4. Substance displacement, or the movement of consumers 
to new substances when their previous drug of choice 
becomes difficult to obtain, for instance through law 
enforcement pressure.
5. The perception and treatment of drug users, who are 
stigmatized, marginalized and excluded.21 
Although governments have increasingly recognized that 
law enforcement strategies for drug control need to be 
integrated into a broader approach with social and public 
health programs, the structures for policymaking, budget 
allocation, and implementation have not modernized at  
the same pace.
 These institutional dynamics obstruct objective and 
evidence-based policymaking. This is more than 
a theoretical problem – repeated studies22,23 have 
demonstrated that governments achieve much greater 
financial and social benefit for their communities by 
investing in health and social programs, rather than 
investing in supply reduction and law enforcement activities. 
However, in most countries, the vast majority of available 
resources are spent on the enforcement of drug laws and 
the punishment of people who use drugs.24 
 The lack of coherence is even more marked at the  
United Nations. The development of the global drug 
control regime involved the creation of three bodies to 
oversee the implementation of the conventions – the UN 
Office on Drugs and Crime (UNODC), the International 
Narcotics Control Board (INCB), and the Commission on 
Narcotic Drugs (CND). This structure is premised on the 
notion that international drug control is primarily a fight 
against crime and criminals. Unsurprisingly, there is a 
built-in vested interest in maintaining the law enforcement 
focus and the senior decisionmakers in these bodies have 
traditionally been most familiar with this framework. 
 Now that the nature of the drug policy challenge has 
changed, the institutions must follow. Global drug policy 
should be created from the shared strategies of all 
interested multilateral agencies – UNODC of course, but 
also UNAIDS, WHO, UNDP, UNICEF, UN Women, the 
World Bank, and the Office of the High Commissioner on 
Human Rights. The marginalization of the World Health 
Organization is particularly worrisome given the fact that  
it has been given a specific mandate under the drug  
control treaties.
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4.  Drug policies must be pursued in a comprehensive 
manner, involving families, schools, public health 
specialists, development practitioners and civil society 
leaders, in partnership with law enforcement agencies 
and other relevant governmental bodies. 
 
 With their strong focus on law enforcement and 
punishment, it is not surprising that the leading 
institutions in the implementation of the drug control 
system have been the police, border control and military 
authorities directed by Ministries of Justice, Security 
or Interior. At the multilateral level, regional or United 
Nations structures are also dominated by these interests. 
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1.  Break the taboo. Pursue an open debate 
and promote policies that effectively reduce 
consumption, and that prevent and reduce harms 
related to drug use and drug control policies. 
Increase investment in research and analysis into  
the impact of different policies and programs.25
 Political leaders and public figures should have the  
courage to articulate publicly what many of them  
acknowledge privately: that the evidence 
overwhelmingly demonstrates that repressive 
strategies will not solve the drug problem, and 
that the war on drugs has not, and cannot, be won. 
Governments do have the power to pursue a mix of 
policies that are appropriate to their own situation, 
and manage the problems caused by drug markets 
and drug use in a way that has a much more positive 
impact on the level of related crime, as well as social 
and health harms. 
2.  Replace the criminalization and punishment of 
people who use drugs with the offer of health and 
treatment services to those who need them. 
 A key idea behind the ‘war on drugs’ approach 
was that the threat of arrest and harsh punishment 
would deter people from using drugs. In practice, 
this hypothesis has been disproved – many countries 
that have enacted harsh laws and implemented 
widespread arrest and imprisonment of drug users and 
low-level dealers have higher levels of drug use and 
related problems than countries with more tolerant 
approaches. Similarly, countries that have introduced 
decriminalization, or other forms of reduction in arrest 
or punishment, have not seen the rises in drug use or 
dependence rates that had been feared.
DECRIMINALIZATION INITIATIVES 
DO NOT RESULT IN SIGNIFICANT 
INCREASES IN DRUG USE
Portugal
In July 2001, Portugal became the first European country 
to decriminalize the use and possession of all illicit drugs. 
Many observers were critical of the policy, believing that 
it would lead to increases in drug use and associated 
problems. Dr. Caitlin Hughes of the University of New 
South Wales and Professor Alex Stevens of the University 
of Kent have undertaken detailed research into the effects 
of decriminalization in Portugal. Their recently published 
findings26 have shown that this was not the case, replicating 
the conclusions of their earlier study27 and that of the  
CATO Institute28.
Hughes and Stevens’ 2010 report detects a slight increase 
in overall rates of drug use in Portugal in the 10 years since 
decriminalization, but at a level consistent with other similar 
countries where drug use remained criminalized. Within this 
general trend, there has also been a specific decline in the 
use of heroin, which was in 2001 the main concern of the 
Portuguese government. Their overall conclusion is that 
the removal of criminal penalties, combined with the use 
of alternative therapeutic responses to people struggling 
with drug dependence, has reduced the burden of drug law 
enforcement on the criminal justice system and the overall 
level of problematic drug use.
Comparing Dutch and US Cities
A study by Reinarman, et. al. compared the very  
different regulatory environments of Amsterdam, whose 
liberal “cannabis cafe” policies (a form of de facto 
decriminalization) go back to the 1970s, and San Francisco, 
in the US, which criminalizes cannabis users. The researchers 
wished to examine whether the more repressive policy 
environment of San Francisco deterred citizens from  
smoking cannabis or delayed the onset of use. They found 
that it did not, concluding that: 
“Our findings do not support claims that criminalization 
reduces cannabis use and that decriminalization increases 
cannabis use... With the exception of higher drug use in  
San Francisco, we found strong similarities across both cities. 
We found no evidence to support claims that criminalization 
reduces use or that decriminalization increases use.”29
RECOMMENDATIONS
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Australia
The state of Western Australia introduced a 
decriminalization scheme for cannabis in 2004, and 
researchers evaluated its impact by comparing prevalence 
trends in that state with trends in the rest of the country. 
The study was complicated by the fact that it took place in 
a period when the use of cannabis was in general decline 
across the country. However, the researchers found that 
this downward trend was the same in Western Australia, 
which had replaced criminal sanctions for the use or 
possession of cannabis with administrative penalties, 
typically the receipt of a police warning called a ‘notice  
of infringement’. The authors state: 
“The cannabis use data in this study suggest that,  
unlike the predictions of those public commentators  
who were critical of the scheme, cannabis use in  
Western Australia appears to have continued to decline 
despite the introduction of the Cannabis Infringement 
Notice Scheme.”30
Comparisons Between Different States in the US
Although cannabis possession is a criminal offense under 
US federal laws, individual states have varying policies 
toward possession of the drug. In the 2008 Report of 
the Cannabis Commission convened by the Beckley 
Foundation, the authors reviewed research that had been 
undertaken to compare cannabis prevalence in those 
states that had decriminalized with those that maintained 
criminal punishments for possession. They concluded that:
“Taken together, these four studies indicated that states 
which introduced reforms did not experience greater 
increases in cannabis use among adults or adolescents. 
Nor did surveys in these states show more favorable 
attitudes towards cannabis use than those states which 
maintained strict prohibition with criminal penalties.”31
 
 In the light of these experiences, it is clear that the 
policy of harsh criminalization and punishment of drug 
use has been an expensive mistake, and governments 
should take steps to refocus their efforts and resources 
on diverting drug users into health and social care 
services. Of course, this does not necessarily mean that 
sanctions should be removed altogether – many drug 
users will also commit other crimes for which they need 
to be held responsible – but the primary reaction to drug 
possession and use should be the offer of appropriate 
advice, treatment and health services to individuals who 
need them, rather than expensive and counterproductive 
criminal punishments.
3.  Encourage experimentation by governments 
with models of legal regulation of drugs (with 
cannabis, for example) that are designed to 
undermine the power of organized crime and 
safeguard the health and security of their citizens.
 The debate on alternative models of drug market 
regulation has too often been constrained by false 
dichotomies – tough or soft, repressive or liberal. In fact, 
we are all seeking the same objective – a set of drug 
policies and programs that minimize health and social 
harms, and maximize individual and national security.  
It is unhelpful to ignore those who argue for a taxed and 
regulated market for currently illicit drugs. This is a  
policy option that should be explored with the same 
rigor as any other.32
 If national governments or local administrations feel that 
decriminalization policies will save money and deliver 
better health and social outcomes for their communities, 
or that the creation of a regulated market may reduce 
the power of organized crime and improve the security 
of their citizens, then the international community should 
support and facilitate such policy experiments and learn 
from their application.
 Similarly, national authorities and the UN need to review 
the scheduling of different substances. The current 
schedules, designed to represent the relative risks and 
harms of various drugs, were set in place 50 years ago 
when there was little scientific evidence on which to 
base these decisions. This has resulted in some obvious 
anomalies – cannabis and coca leaf, in particular, now 
seem to be incorrectly scheduled and this needs to  
be addressed.
11
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Most Dangerous
Moderate Risk
Low Risk
Not Subject to International Control
UN CLASSIFICATION
Heroin
Cocaine
Barbiturates
Alcohol
Ketamine
Benzodiazepines
Amphetamine
Tobacco
Buprenorphine
Cannabis
Solvents
LSD
Ritalin
Anabolic Steroids
GHB
Ecstasy
Khat
 0.0 0.5 1.0 1.5 2.0 2.5 3.0 
INDEPENDENT EXPERT 
ASSESSMENTS OF RISK
In a report published by The Lancet in 2007, a team of 
scientists33 attempted to rank a range of psychoactive 
drugs according to the actual and potential harms they 
could cause to society. The graph at right summarizes 
their findings and contrasts them with the seriousness 
with which the drugs are treated within the global 
drug control system. 
While these are crude assessments, they clearly 
show that the categories of seriousness ascribed to 
various substances in international treaties need to be 
reviewed in the light of current scientific knowledge.
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4.  Establish better metrics, indicators and goals to 
measure progress.
 The current system of measuring success in the drug 
policy field is fundamentally flawed.34 The impact of 
most drug strategies are currently assessed by the level 
of crops eradicated, arrests, seizures and punishments 
applied to users, growers and dealers. In fact, arresting 
and punishing drug users does little to reduce levels 
of drug use, taking out low-level dealers simply creates 
a market opportunity for others, and even the largest 
and most successful operations against organized 
criminals (that take years to plan and implement) have 
been shown to have, at best, a marginal and short-
lived impact on drug prices and availability. Similarly, 
eradication of opium, cannabis or coca crops merely 
displaces illicit cultivation to other areas.
 A new set of indicators is needed to truly show the 
outcomes of drug policies, according to their harms or 
benefits for individuals and communities – for example, 
the number of victims of drug market-related violence 
and intimidation; the level of corruption generated 
by drug markets; the level of petty crime committed 
by dependent users; levels of social and economic 
development in communities where drug production, 
selling or consumption are concentrated; the level of 
drug dependence in communities; the level of overdose 
deaths; and the level of HIV or hepatitis C infection 
among drug users. Policymakers can and should 
articulate and measure the outcome of these objectives.
 The expenditure of public resources should therefore 
be focused on activities that can be shown to have 
a positive impact on these objectives. In the current 
circumstances in most countries, this would mean 
increased investment in health and social programs, 
and improved targeting of law enforcement resources 
to address the violence and corruption associated with 
drug markets.35 In a time of fiscal austerity, we can no 
longer afford to maintain multibillion dollar investments 
that have largely symbolic value.
5.  Challenge, rather than reinforce, common 
misconceptions about drug markets, drug use  
and drug dependence.  
 Currently, too many policymakers reinforce the idea 
that all people who use drugs are ‘amoral addicts’, and 
all those involved in drug markets are ruthless criminal 
masterminds. The reality is much more complex.  
The United Nations makes a conservative estimate 
that there are currently 250 million illicit drug users in 
the world, and that there are millions more involved 
in cultivation, production and distribution. We simply 
cannot treat them all as criminals.
 To some extent, policymakers’ reluctance to 
acknowledge this complexity is rooted in their 
understanding of public opinion on these issues.  
Many ordinary citizens do have genuine fears about the 
negative impacts of illegal drug markets, or the behavior 
of people dependent on, or under the influence of, 
illicit drugs. These fears are grounded in some general 
assumptions about people who use drugs and drug 
markets, that government and civil society experts need 
to address by increasing awareness of some established 
(but largely unrecognized) facts. For example: 
•	 The	majority	of	people	who	use	drugs	do	not	fit	the	
stereotype of the ‘amoral and pitiful addict’. Of the 
estimated 250 million drug users worldwide, the United 
Nations estimates that less than 10 percent can be 
classified as dependent, or ‘problem drug users’.36 
•	 Most	people	involved	in	the	illicit	cultivation	of	coca,	
opium poppy, or cannabis are small farmers struggling 
to make a living for their families. Alternative livelihood 
opportunities are better investments than destroying 
their only available means of survival.
•	 The	factors	that	influence	an	individual’s	decision	to	
start using drugs have more to do with fashion, peer 
influence, and social and economic context, than with 
the drug’s legal status, risk of detection, or government 
prevention messages.37, 38
•	 The	factors	that	contribute	to	the	development	of	
problematic or dependent patterns of use have more 
to do with childhood trauma or neglect, harsh living 
conditions, social marginalization, and emotional 
problems, rather than moral weakness or hedonism.39 
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•	 It	is	not	possible	to	frighten	or	punish	someone	out	of	drug	
dependence, but with the right sort of evidence-based 
treatment, dependent users can change their behavior and 
be active and productive members of the community.40
•	 Most	people	involved	in	drug	trafficking	are	petty	dealers	
and not the stereotyped gangsters from the movies – the 
vast majority of people imprisoned for drug dealing or 
trafficking are ‘small fish’ in the operation (often coerced 
into carrying or selling drugs), who can easily be replaced 
without disruption to the supply.41,42 
 A more mature and balanced political and media discourse 
can help to increase public awareness and understanding. 
Specifically, providing a voice to representatives of farmers, 
users, families and other communities affected by drug 
use and dependence can help to counter myths and 
misunderstandings.
6.  Countries that continue to invest mostly in a law 
enforcement approach (despite the evidence) should 
focus their repressive actions on violent organized 
crime and drug traffickers, in order to reduce the  
harms associated with the illicit drug market. 
 The resources of law enforcement agencies can be much 
more effectively targeted at battling the organized crime 
groups that have expanded their power and reach on the 
back of drug market profits. In many parts of the world,  
the violence, intimidation and corruption perpetrated  
by these groups is a significant threat to individual and 
national security and to democratic institutions, so efforts  
by governments and law enforcement agencies to curtail 
their activities remain essential. 
 However, there is a need to review our tactics in this fight. 
There is a plausible theory put forward by MacCoun and 
Reuter43 that suggests that supply reduction efforts are 
most effective in a new and undeveloped market, where 
the sources of supply are controlled by a small number 
of trafficking organizations. Where these conditions exist, 
appropriately designed and targeted law enforcement 
operations have the potential to stifle the emergence of  
new markets. We face such a situation now in West Africa. 
On the other hand, where drug markets are diverse and 
well-established, preventing drug use by stopping supply 
is not a realistic objective. 
DRUGS IN WEST AFRICA: 
RESPONDING TO THE GROWING 
CHALLENGE OF NARCOTRAFFIC 
AND ORGANIZED CRIME
In just a few years, West Africa has become a major transit 
and re-packaging hub for cocaine following a strategic shift 
of Latin American drug syndicates toward the European 
market. Profiting from weak governance, endemic poverty, 
instability and ill-equipped police and judicial institutions, 
and bolstered by the enormous value of the drug trade, 
criminal networks have infiltrated governments, state 
institutions and the military. Corruption and money 
laundering, driven by the drug trade, pervert local politics 
and skew local economies. 
A dangerous scenario is emerging as narco-traffic threatens 
to metastasize into broader political and security challenges. 
Initial international responses to support regional and 
national action have not been able to reverse this trend.  
New evidence44 suggests that criminal networks are 
expanding operations and strengthening their positions 
through new alliances, notably with armed groups. Current 
responses need to be urgently scaled up and coordinated 
under West African leadership, with international financial 
and technical support. Responses should integrate 
law enforcement and judicial approaches with social, 
development and conflict prevention policies – and they 
should involve governments and civil society alike. 
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We also need to recognize that it is the illicit nature of the 
market that creates much of the market-related violence 
– legal and regulated commodity markets, while not 
without problems, do not provide the same opportunities 
for organized crime to make vast profits, challenge the 
legitimacy of sovereign governments, and, in some cases,  
fund insurgency and terrorism. 
This does not necessarily mean that creating a legal  
market is the only way to undermine the power and 
reach of drug trafficking organizations. Law enforcement 
strategies can explicitly attempt to manage and shape 
the illicit market by, for example, creating the conditions 
where small-scale and private ‘friendship network’ types 
of supply can thrive, but cracking down on larger-scale 
operations that involve violence or inconvenience to the 
general public. Similarly, the demand for drugs from those 
dependent on some substances (for example, heroin) 
can be met through medical prescription programs that 
automatically reduce demand for the street alternative. 
Such strategies can be much more effective in reducing 
market-related violence and harms than futile attempts  
to eradicate the market entirely. 
On the other hand, poorly designed drug law enforcement 
practices can actually increase the level of violence, 
intimidation and corruption associated with drug 
markets. Law enforcement agencies and drug trafficking 
organizations can become embroiled in a kind of ‘arms 
race’, in which greater enforcement efforts lead to a similar 
increase in the strength and violence of the traffickers. 
In this scenario, the conditions are created in which the 
most ruthless and violent trafficking organizations thrive. 
Unfortunately, this seems to be what we are currently 
witnessing in Mexico and many other parts of the world.
LAW ENFORCEMENT AND 
THE ESCALATION OF VIOLENCE
A group of academics and public health experts based 
in British Columbia have conducted a systematic review 
of evidence45 relating to the impact of increased law 
enforcement on drug market-related violence (for example, 
armed gangs fighting for control of the drug trade, or 
homicide and robberies connected to the drug trade).
In multiple US locations, as well as in Sydney, Australia, 
the researchers found that increased arrests and law 
enforcement pressures on drug markets were strongly 
associated with increased homicide rates and other  
violent crimes. Of all the studies examining the effect of 
increased law enforcement on drug market violence,  
91 percent concluded that increased law enforcement 
actually increased drug market violence. The researchers 
concluded that: 
 “The available scientific evidence suggests that  
increasing the intensity of law enforcement interventions 
to disrupt drug markets is unlikely to reduce drug gang 
violence. Instead, the existing evidence suggests that  
drug-related violence and high homicide rates are likely 
a natural consequence of drug prohibition and that 
increasingly sophisticated and well-resourced methods of 
disrupting drug distribution networks may unintentionally 
increase violence.”46
In the UK also, researchers have examined the effects of 
policing on drug markets, noting that:
“Law enforcement efforts can have a significant negative 
impact on the nature and extent of harms associated with 
drugs by (unintentionally) increasing threats to public 
health and public safety, and by altering both the behavior 
of individual drug users and the stability and operation of 
drug markets (e.g. by displacing dealers and related activity 
elsewhere or increasing the incidence of violence  
as displaced dealers clash with established ones).”47
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7.  Promote alternative sentences for small-scale and 
first-time drug dealers.
 While the idea of decriminalization has mainly been 
discussed in terms of its application to people who use 
drugs or who are struggling with drug dependence,  
we propose that the same approach be considered  
for those at the bottom of the drug selling chain.  
The majority of people arrested for small-scale drug 
selling are not gangsters or organized criminals.  
They are young people who are exploited to do the  
risky work of street selling, dependent drug users trying 
to raise money for their own supply, or couriers coerced 
or intimidated into taking drugs across borders. These 
people are generally prosecuted under the same legal 
provisions as the violent and organized criminals who 
control the market, resulting in the indiscriminate 
application of severe penalties.
 Around the world, the vast majority of arrests are of 
these nonviolent and low-ranking ‘little fish’ in the drug 
market. They are most visible and easy to catch, and do 
not have the means to pay their way out of trouble.48 
The result is that governments are filling prisons with 
minor offenders serving long sentences, at great cost, 
and with no impact on the scale or profitability of  
the market. 
 In some countries, these offenders are even subject to 
the death penalty, in clear contravention of international 
human rights law. To show their commitment to 
fighting the drug war, many countries implement laws 
and punishments that are out of proportion to the 
seriousness of the crime, and that still do not have a 
significant deterrent effect. The challenge now is for 
governments to look at diversion options for the ‘little 
fish’, or to amend their laws to make a clearer and more 
proportionate distinction between the different types of 
actors in the drug market.   
8.  Invest more resources in evidence-based prevention, 
with a special focus on youth.
 Clearly, the most valuable investment would be in 
activities that stop young people from using drugs in 
the first place, and that prevent experimental users 
from becoming problematic or dependent users. 
Prevention of initiation or escalation is clearly preferable 
to responding to the problems after they occur. 
Unfortunately, most early attempts at reducing overall 
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rates of drug use through mass prevention campaigns 
were poorly planned and implemented. While the 
presentation of good (and credible) information on 
the risks of drug use is worthwhile, the experience of 
universal prevention (such as media campaigns, or 
school-based drug prevention programs) has been 
mixed. Simplistic ‘just say no’ messages do not seem  
to have a significant impact.49 
 There have been some carefully planned and targeted 
prevention programs, however, that focus on social skills 
and peer influences that have had a positive impact on 
the age of initiation or the harms associated with drug 
use. The energy, creativity and expertise of civil society 
and community groups are of particular importance 
in the design and delivery of these programs. Young 
people are less likely to trust prevention messages 
coming from state agencies. 
 Successful models of prevention have tended to target 
particular groups at risk – gang members, children in 
care, or in trouble at school or with the police – with 
mixed programs of education and social support that 
prevent a proportion of them from developing into 
regular or dependent drug users. Implemented to a  
sufficient scale, these programs have the potential 
to reduce the overall numbers of young people who 
become drug dependent or who get involved in  
petty dealing.
9.  Offer a wide and easily accessible range of options 
for treatment and care for drug dependence, 
including substitution and heroin-assisted treatment, 
with special attention to those most at risk, including 
those in prisons and other custodial settings.
 In all societies and cultures, a proportion of individuals 
will develop problematic or dependent patterns of 
drug use, regardless of the preferred substances in that 
society or their legal status. Drug dependence can be 
a tragic loss of potential for the individual involved, 
but is also extremely damaging for their family, their 
community, and, in aggregate, for the entire society. 
 Preventing and treating drug dependence is therefore 
a key responsibility of governments – and a valuable 
investment, since effective treatment can deliver 
significant savings in terms of reductions in crime and 
improvements in health and social functioning. 
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 UN drug control institutions have largely acted as 
defenders of traditional policies and strategies. In the 
face of growing evidence of the failure of these strategies, 
reforms are necessary. There has been some encouraging 
recognition by UNODC that there is a need to balance 
and modernize the system, but there is also strong 
institutional resistance to these ideas.
 Countries look to the UN for support and guidance.  
The UN can, and must, provide the necessary leadership 
to help national governments find a way out of the current 
policy impasse. We call on UN Secretary General Ban 
Ki-moon and UNODC Executive Director Yury Fedotov 
to take concrete steps toward a truly coordinated and 
coherent global drug strategy that balances the need 
to stifle drug supply and fight organized crime with the 
need to provide health services, social care, and economic 
development to affected individuals and communities.
 There are a number of ways to make progress on this 
objective. For a start, the UN could initiate a wide-
ranging commission to develop a new approach; UN 
agencies could create new and stronger structures for 
policy coordination; and the UNODC could foster more 
meaningful program coordination with other UN agencies 
such as the WHO, UNAIDS, UNDP, or the Office of the  
UN High Commissioner for Human Rights. 
11. Act urgently: the war on drugs has failed, and  
policies need to change now.
 There are signs of inertia in the drug policy debate in 
some parts of the world, as policymakers understand  
that current policies and strategies are failing but do not 
know what to do instead. There is a temptation to avoid 
the issue. This is an abdication of policy responsibility –  
for every year we continue with the current approach, 
billions of dollars are wasted on ineffective programs, 
millions of citizens are sent to prison unnecessarily, 
millions more suffer from the drug dependence of 
loved ones who cannot access health and social care 
services, and hundreds of thousands of people die from 
preventable overdoses and diseases contracted through 
unsafe drug use. 
 There are other approaches that have been proven to 
tackle these problems that countries can pursue now. 
Getting drug policy right is not a matter for theoretical or 
intellectual debate – it is one of the key policy challenges 
of our time.
 Many successful treatment models – using a mix of 
substitution treatment and psycho-social methods 
– have been implemented and proven in a range of 
socio-economic and cultural settings. However, in 
most countries, the availability of these treatments is 
limited to single models, is only sufficient to meet a 
small fraction of demand, or is poorly targeted and fails 
to focus resources on the most severely dependent 
individuals. National governments should therefore 
develop comprehensive, strategic plans to scale  
up a menu of evidence-based drug dependence 
treatment services. 
 At the same time, abusive practices carried out in the 
name of treatment – such as forced detention, forced 
labor, physical or psychological abuse – that contravene 
human rights standards by subjecting people to cruel, 
inhuman and degrading treatment, or by removing 
the right to self-determination, should be abolished. 
Governments should ensure that their drug dependence 
treatment facilities are evidence-based and comply with 
international human rights standards. 
10.The United Nations system must provide leadership 
in the reform of global drug policy. This means 
promoting an effective approach based on evidence, 
supporting countries to develop drug policies  
that suit their context and meet their needs, and 
ensuring coherence among various UN agencies, 
policies and conventions.
 While national governments have considerable 
discretion to move away from repressive policies, 
the UN drug control system continues to act largely 
as a straitjacket, limiting the proper review and 
modernization of policy. For most of the last century, 
it has been the US government that has led calls for 
the development and maintenance of repressive drug 
policies. We therefore welcome the change of tone 
emerging from the current administration50 – with 
President Obama himself acknowledging the futility 
of a ‘war on drugs’ and the validity of a debate on 
alternatives.51 It will be necessary, though, for the US to 
follow up this new rhetoric with real reform, by reducing 
its reliance on incarceration and punishment of drug 
users, and by using its considerable diplomatic influence 
to foster reform in other countries.
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DRUG POLICY
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is to bring to the international level an informed,  
science-based discussion about humane and effective 
ways to reduce the harm caused by drugs to people  
and societies.
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•	 Review	the	basic	assumptions,	effectiveness	and	
consequences of the ‘war on drugs’ approach 
•	 Evaluate	the	risks	and	benefits	of	different	national	
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